Clinical implications of healthcare-associated infection in patients with community-onset acute pyelonephritis

Scand J Infect Dis. 2011 Aug;43(8):587-95. doi: 10.3109/00365548.2011.572907. Epub 2011 Apr 1.

Abstract

Background: Clinical and microbiological characteristics of healthcare-associated acute pyelonephritis (HCA-APN) have not been described in detail yet. We sought to delineate the differences between community-associated (CA)- and HCA-APN with specific interest in antibiotic resistance of causative microorganisms.

Methods: We conducted a retrospective cohort study during a 1-y period at a large referral center. Patients who visited the emergency department with symptoms and signs of APN were included in the study population.

Results: Among 319 cases with community-onset APN, 201 cases (63%) were classified as HCA-APN. Patients with HCA-APN had higher SOFA (sequential organ failure assessment) scores, longer length of hospital stay and a lower rate of complete response to antimicrobial therapy. Patients with complicated APN also had characteristics similar to those seen in HCA-APN. However, 14-day mortality rates were not different between CA-APN vs HCA-APN and between uncomplicated APN vs complicated APN. With regard to microbiological characteristics, Escherichia coli were less common in HCA-APN than in CA-APN (62.7% vs 93.2%, p < 0.001). Among E. coli isolates, quinolone resistance and extended-spectrum beta-lactamase (ESBL) production were more common in HCA-APN than in CA-APN (38.9% vs 12.7%, p < 0.001; 15.9% vs 0.8%, p < 0.001, respectively).

Conclusions: HCA-APN, and complicated APN, represents a distinct subset of urinary tract infections with more antibiotic-resistant pathogens and worse outcomes, which physicians should consider to provide optimal treatment.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Disease
  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Anti-Bacterial Agents / therapeutic use
  • Community-Acquired Infections / complications
  • Community-Acquired Infections / drug therapy
  • Community-Acquired Infections / epidemiology*
  • Cross Infection / complications
  • Cross Infection / drug therapy
  • Cross Infection / epidemiology*
  • Drug Resistance, Bacterial
  • Female
  • Humans
  • Logistic Models
  • Male
  • Middle Aged
  • Pyelonephritis / complications
  • Pyelonephritis / drug therapy
  • Pyelonephritis / epidemiology*
  • Retrospective Studies
  • Risk Factors
  • Statistics, Nonparametric
  • Treatment Outcome

Substances

  • Anti-Bacterial Agents